Genetic Causes
Proprotein convertase subtilisin/kexin type 1 deficiency is caused by mutations in the PCSK1 gene. This gene provides instructions for making an enzyme called proprotein convertase 1/3 (PC1/3). This enzyme acts like a molecular scissor, cutting inactive precursor proteins (prohormones) to turn them into active hormones such as insulin, glucagon, and pro-opiomelanocortin (POMC) derivatives. When the gene is mutated, the enzyme does not work correctly, and these hormones are not activated. This leads to the wide range of symptoms seen in the disorder, from digestion to appetite control.

Inheritance and Risk Factors
The condition is inherited in an autosomal recessive pattern. This means a child must inherit two copies of the mutated gene, one from each parent, to develop the condition. Parents who each carry one copy of the mutated gene are called carriers; they typically do not show symptoms of the condition themselves but have a 25% chance of having an affected child with each pregnancy. The primary risk factor is a family history of the condition or consanguinity (parents who are related by blood), which increases the likelihood of rare recessive genetic disorders.

Prevention
Because PCSK1 deficiency is a genetic disorder, there is no way to prevent the mutation from occurring. However, for families with a known history of the condition, genetic counseling and testing can help parents understand their risks before having children. Once a child is born with the condition, management focuses on preventing complications rather than preventing the disease itself.

Signs and Symptoms
The symptoms of PCSK1 deficiency often change as a child grows. In newborns and infants, the most prominent sign is severe diarrhea that prevents the absorption of nutrients (malabsorptive diarrhea). This often leads to failure to thrive, dehydration, and a condition called metabolic acidosis. As the child survives infancy (usually after age 2 or 3), the digestive symptoms often improve, but new symptoms appear. The child develops an insatiable hunger (hyperphagia) and experiences rapid weight gain, leading to severe obesity.

Hormonal and Systemic Effects
Other signs related to hormonal imbalances may include:

• Reactive Hypoglycemia: Low blood sugar levels that occur after eating.
• Adrenal Insufficiency: Low levels of cortisol (hypocortisolism), which can be life-threatening during stress.
• Hypogonadism: Delayed or absent puberty due to low sex hormones.
• Thyroid Issues: Central hypothyroidism, leading to fatigue and slow metabolism.
• Diabetes Insipidus Symptoms: Excessive thirst (polydipsia) and urination (polyuria).

Diagnosis
Clinicians may suspect PCSK1 deficiency in an infant with unexplained severe diarrhea or a young child with extreme obesity and hormonal deficiencies. Diagnosis is confirmed through genetic testing, which identifies mutations in the PCSK1 gene. Blood tests may also reveal specific patterns, such as high levels of proinsulin (the inactive precursor to insulin) disproportionate to insulin levels, or low cortisol levels.

Medications and Hormone Replacement
Treatment for PCSK1 deficiency is multifaceted and often requires a team of specialists. A key advance in treatment is the use of setmelanotide, a medication approved for chronic weight management in patients with this specific genetic deficiency. Setmelanotide helps control the severe hunger and obesity associated with the condition. Additionally, patients typically require lifelong hormone replacement therapy to address specific deficiencies. This may include hydrocortisone for adrenal insufficiency, levothyroxine for thyroid issues, and sex hormones to induce puberty at the appropriate age.

Dietary and Digestive Management
In infancy, the primary focus is managing severe diarrhea. This often requires specialized amino acid-based formulas or, in severe cases, intravenous feeding (parenteral nutrition) to ensure the baby grows. As the child gets older and hyperphagia sets in, strict dietary supervision is necessary to manage weight, although diet alone is rarely sufficient to control the biological drive to eat without medication.

When to See a Doctor
Parents should seek immediate medical care if a child with this condition shows signs of adrenal crisis, such as severe weakness, vomiting, or confusion, especially during illness or stress. Routine follow-up is essential to monitor growth, hormone levels, and the effectiveness of medications. Consult a healthcare provider if:

• Diarrhea worsens or leads to signs of dehydration.
• There are episodes of low blood sugar (shakiness, sweating, confusion).
• Weight gain becomes rapid and uncontrollable.

Severity and Complications
PCSK1 deficiency is a serious condition. In the first years of life, the severity is driven by gastrointestinal distress; severe malabsorptive diarrhea can lead to dangerous dehydration and malnutrition. If not properly recognized and treated, this phase can be fatal. In childhood and adulthood, the severity is linked to extreme obesity and endocrine dysfunction. Complications can include orthopedic problems, sleep apnea, and metabolic issues resulting from excess weight.

Prognosis
The long-term outlook has improved significantly with better recognition and treatment options. Historically, mortality was high in infancy due to digestive failure. Today, with appropriate nutritional support and hormone replacement, life expectancy can approach normal ranges. The approval of targeted therapies like setmelanotide has also improved the prognosis regarding obesity management. However, the condition remains chronic and requires lifelong medical surveillance to adjust hormone dosages and manage weight-related risks.

Daily Challenges and Coping
Living with PCSK1 deficiency involves strict routines. For parents of infants, daily life revolves around managing feeding and hygiene due to chronic diarrhea. As the child grows, the focus shifts to managing an insatiable appetite. Families often need to lock kitchen cabinets and refrigerators to prevent uncontrolled eating. This can be emotionally taxing for both the child and the caregivers. Socially, children may face stigma due to obesity, which can affect mental health. Connecting with support groups for rare genetic obesity disorders can provide community and practical tips.

Questions to Ask Your Healthcare Provider
Being prepared for medical appointments can help you manage this complex condition. Consider asking:

• What specific hormone levels need to be monitored right now?
• How often should we schedule blood tests to check for diabetes or adrenal issues?
• Is my child a candidate for setmelanotide or other new therapies?
• What is the best emergency plan if my child becomes ill or has an adrenal crisis?
• Can you refer us to a nutritionist or genetic counselor familiar with this disorder?

Q: Is PCSK1 deficiency the same as general obesity?
A: No. PCSK1 deficiency is a specific genetic disorder where a missing enzyme causes hormonal failures and a biological drive to eat that cannot be controlled by willpower alone. It is distinct from lifestyle-related obesity.

Q: Can the condition be cured?
A: Currently, there is no cure for the underlying genetic mutation. However, the symptoms can be treated effectively with hormone replacement and specific medications to manage weight.

Q: Will my other children have this condition?
A: Because it is a recessive genetic disorder, if both parents are carriers, there is a 25% chance with each pregnancy that the child will have the condition. Genetic counseling can provide specific risk assessments for your family.

Q: Does the diarrhea go away?
A: In many cases, the severity of the diarrhea improves significantly as the child grows out of infancy, although some digestive sensitivity may persist.